Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases

Details for Australian Patent Application No. 2011226174 (hide)

Owner Janssen Pharmaceutica NV

Inventors Bartolome-Nebreda, Jose Manuel; Conde-Ceide, Susana; Macdonald, Gregor James; Pastor-Fernandez, Joaquin; Van Gool, Michiel Luc Maria; Mar- tin-Martin, Maria Luz; Vanhoof, Greta Constantia Peter

Agent Shelston IP

Pub. Number AU-A-2011226174

PCT Pub. Number WO2011/110545

Priority 10155981.3 09.03.10 EP

Filing date 8 March 2011

Wipo publication date 15 September 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 3/00 Drugs for disorders of the metabolism

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/110545 Priority application(s): WO2011/110545

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011226179-Process for the preparation of an antimicrobial article

2011226160-Conjugation process of bacterial polysaccharides to carrier proteins